РОЛЬ РАРР-А В РАЗВИТИИ ПОВРЕЖДЕНИЯ АТЕРОСКЛЕРОТИЧЕСКОЙ БЛЯШКИ У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА

1. Панченко Е.П. Механизмы развития острого коронарного синдрома. Русск. мед. журн.2000;8:359-360.

2. О.П. Шевченко, О.Д. Мишнев. Ишемическая болезнь сердца. Реафарм, Москва, 2005.

3. Шевченко А.О. Новые лабораторные маркеры ангиогенеза и повреждения атеросклеротической бляшки // Клиническая лабораторная диагностика-2006.-№6- С.23-50

4. Шевченко О.П., Орлова О.В., Казаков Э.Н. и др. Клиническое значение ассоциированного с беременностью протеина плазмы А (РАРР-А) при васкулопатии трансплантированного сердца // Вестник трансплантологии и искусственных органов. – 2008. – №5. – С. 23-28.

5. Bayes-Genis A, Conover CA, Overgaard MT, et al. Pregnancyassociated plasma protein A as a marker of acute coronary syndromes // N Engl J Med. 2001;345. – Р.1022-1029

6. A. Bayes-Genis, C.A. Conover and R.S. Schwartz, The insulin-like growth factor axis. A review of atherosclerosis and restenosis // Circ Res; 2000, 86 – Р. 125–130.

7. Beaudeux JL, Burc L, Imbert-Bismut F, Giral P, Bernard M, Bruckert E, Chapman MJ. Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk // Arterioscler Thromb Vasc Biol 2003;23. – Р.7–10.

8. Bunn R.C., Fowlkes J.L. Insulin-like growth factor binding protein proteolysis // Trends Endocrinol Metab;2003; 14. – Р.176-181.

9. Ceska R, Stulc T, Zima T, et al. PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to // Atherosclerosis 2003;166. – Р.195–196.

10. Cheryl A. Conover, Sean C. Harrington, and Laurie K. Bale Differential Regulation of Pregnancy Associated Plasma Protein-A in Human Coronary Artery Endothelial Cells and Smooth Muscle Cells Growth Horm // IGF Res.;2008; 18(3). – Р.213–220.

11. Consuegra-Sanchez L, Petrovic I, Cosin-Sales J, et al. Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (proMBP) levels in patients with chronic stable angina pectoris // Clin Chim Acta. 2008; 391(1-2). – Р.18-23.

12. Consuegra-Sanchez L, Fredericks S, Kaski JC. Pregnancyassociated plasma protein-A (PAPP-A) and cardiovascular risk // Atherosclerosis; 2008, 12; P 123-126.

13. Cosin-Sales J, Christiansen M, Kaminski P, et al. Pregnancyassociated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris// Circulation 2004;109. – Р.1724-1728.

14. Cosin-Sales J, Kaski JC, Christiansen M et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris // Eur Heart J. – 2005. – 26(20). – P.2093-2098.

15. Crea F., Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend or foe? // Eur Heart J, 2005;26. – Р.2076-2076.

16. Dominguez-Rodriguez, P. Abreu-Gonzalez, M. Garcia-Gonzalez, et al. Circulating pregnancy-associated plasma protein A is not an early marker of acute myocardial infarction // Clin Biochem; 2004; 10; P102-106.

17. Elesber AA, Conover CA, Denktas AE, et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina // Eur Heart J. 2006;27(14). – Р.1678-84.

18. Fialová L, Pilecková N, Bauer J, et al. Pregnancy-associated plasma protein-A in patients with cerebrovascular diseases--a pilot study // Prague Med Rep. 2006;107(1). – Р.37-45.

19. Hong MK, Mintz GS, Lee CW. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients // Circulation; 2004;110. – Р.928-933.

20. Iversen KK, Teisner AS, Teisner B, et al. Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction // Am J Cardiol. 2008; 15;101(10). – Р.1389-94.

21. Iversen KK, Teisner AS, Teisner B, et al. Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome // Clin Biochem. 2009;42(9). – Р.828-834.

22. Kavsak PA, Wang X, Henderson M, et al. PAPP-A as a marker of increased long-term risk in patients with chest pain // Clin Biochem. 2009;42(10-11). – Р.1012-1018.

23. Khosravi J, Diamandi A, Krishna RG, et al. Pregnancy associated plasma protein-A: ultrasensitive immunoassay and determination in coronary heart disease // Clin Biochem 2002;35. – Р. 531–538.

24. Lauzurica R, Pastor C, Bayés B, et al. Pretransplant inflammation: a risk factor for delayed graft function? // JNephrol; 2008; 21; P. 221- 228.

25. Lauzurica R, Pastor C, Bayés B, et al. Pretransplant pregnancyassociated plasma protein-a as a predictor of chronic allograft nephropathy and posttransplant cardiovascular events // Transplantation. 2005; 27;80(10). – Р.1441-1446.

26. Lee RT, Schoen FJ, Loree HM, et al. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis: implications for plaque rupture // Arterioscler Thromb Vasc Biol. 1996.-16.- P.1070–1073.

27. Li WP, Gu FS, Jia SQ. Effects of C-reactive protein and tumor necrosis factor-alpha on mRNA expression of pregnancy-associated plasma protein-A in monocytes// Zhonghua Xin Xue Guan Bing Za Zhi. 2006.-34(12).- P.1117-21.

28. Li X, Liu Q, Zhou T, et al. PAPP-A: a possible pathogenic link to the instability of atherosclerotic plaque // Med Hypotheses. 2008;70(3). – Р.597-599.

29. Li XP, Zhou SH, Tang JJ, et al. Changes of plasma CD40L and PAPP-A in patients with acute coronary syndrome after the PCI operation // Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007;32(6). – Р.1098-1101.

30. Li XP, Zhou SH, Tang JJ, et al. Association between plasma pregnancyassociated plasma protein a and restenosis after percutaneous coronary angioplasty // Circ J. 2008;7 2(5). – Р.729-733.

31. Liu ZY, Zhang JY, Sun TW, et al. Levels of pregnancy-associated plasma protein A in patients with coronary artery disease // Clin Invest Med. 2008;31(2). – Р.85-89.

32. Lund J, Qin QP, Ilva T, et al. Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation // Circulation. 2003;108. – Р.1924–1926.

33. Mueller T, Dieplinger B, Poelz W, et al. Increased pregnancyassociated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease Study // Clin Chem. 2006 Jun;52(6):1096-103. Epub 2006 Apr 13. Links Comment in: Clin Chem. 2006;52(6). – Р. 913-4.

34. Qin QP, Kokkala S, Lund J, et al. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy // Clin Chem 2005;51. – Р.75-83.

35. Qin QP, Wittfooth S, Pettersson K. Measurement and clinical significance of circulating PAPP-A in ACS patients // Clin Chim Acta. 2007; 1; 380(1-2). – Р.59-67.

36. Rossen M, Iversen K, Teisner A, et al. Optimisation of sandwich ELISA based on monoclonal antibodies for the specific measurement of pregnancy-associated plasma protein (PAPP-A) in acute coronary syndrome // Clin Biochem. -2007.-40(7).- P.478-484.

37. Sangiorgi G, Mauriello A, Bonanno E et al. Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events // J Am Coll Cardiol. – 2006. – 6;47(11). – P.2201-2211.

38. Shah PK, Galis ZS. Matrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain // Circulation. 2001;104. – Р.1878–1880.

39. Terkelsen CJ, Oxvig C, Norgaard BL, et al. Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration // Am J Cardiol. 2009; 1;103(1). – Р. 29-35.

40. Wittfooth S, Qin QP, Lund J, et al. Immunofluorometric pointof-care assays for the detection of acute coronary syndromerelated noncomplexed pregnancy-associated plasma protein A // Clin Chem. 2006;52(9). –Р. 1794-801.